Author(s):
Mekala Sabareesh, Janapati Pedda Yanadaiah, Kothapalli Bannoth Chandrasekhar
Email(s):
sabareesh85@gmail.com
DOI:
10.52711/0974-360X.2021.01067 
Address:
Mekala Sabareesh1*, Janapati Pedda Yanadaiah2, Kothapalli Bannoth Chandrasekhar3
1Research Scholar, Jawaharlal Nehru Technological University, Anantapur, Ananthapuramu, Andhra Pradesh, India.
2Professor, Dr. K.V. Subba Reddy Institute of Pharmacy, Kurnool, Andhra Pradesh, India.
3Professor, Department of Chemistry, Krishna University, Machilipatnam, Andhra Pradesh, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 11,
Year - 2021
ABSTRACT:
Nanotechnology is an emerging technology that has brought the upheaval reforms in the domain of pharmaceutical sciences including the development of nanovesicular drug delivery carriers such as proniosomes, niosomes, liposomes, ethosomes, etc. Among them, proniosomes become superior and they surmount the problems of other vesicular carriers. Proniosomes are nano-sized vesicular structures of dry, free-flowing powder (or) gel with encapsulation of drugs in the vesicle that produce multilamellar niosomal dispersion after hydration and they possess the capacity to enhance solubility, permeability and bioavailability of diverse drugs. Proniosomes are suitable to deliver the drugs efficiently through transdermal route to accomplish controlled release action, increased therapeutic effectiveness to various diseases and upon application to the skin, the proniosmes are modified into niosomes in situ by hydration of water from the skin. This study aims to discuss different aspects of proniosomes such as merits, mechanism, types, components, preparation, characterization, drug release, market scenario, future trends and to explore proniosomes for various pharmaceutical applications in drug delivery via different routes, such as topical, transdermal, oral, parenteral, ocular, vaginal, nebulizer and intranasal routes. These proniosomes-derived niosomes are better and may offer an excellent, inexpensive alternative delivery, much more beneficial than other vesicular and conventional dosage forms.
Cite this article:
Mekala Sabareesh, Janapati Pedda Yanadaiah, Kothapalli Bannoth Chandrasekhar. Novel Nanoproniosomal Vesicular carriers for the effective and efficient Drug Delivery: Fundamentals, Recent Advancements and Applications. Research Journal of Pharmacy and Technology. 2021; 14(11):6155-5. doi: 10.52711/0974-360X.2021.01067
Cite(Electronic):
Mekala Sabareesh, Janapati Pedda Yanadaiah, Kothapalli Bannoth Chandrasekhar. Novel Nanoproniosomal Vesicular carriers for the effective and efficient Drug Delivery: Fundamentals, Recent Advancements and Applications. Research Journal of Pharmacy and Technology. 2021; 14(11):6155-5. doi: 10.52711/0974-360X.2021.01067 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-11-92
REFERENCES:
1. Umekar M.J., Biyani D.M., Amgaonkar Y.M., Bhoyar P.K., Lade U.B. and Kalsait R.P. Formulation Development and Evaluation of Transdermal Drug Delivery System of Antihypertensive Drug. Research J. Pharm. and Tech. 2010; 3 (3): 753-757.
2. Indira U, Uma Shankar MS. Proniosomes as a drug carrier: A review. Int J Pharm Sci Res. 2012; 3 (12): 4617-4625.
3. Venkata Ramesh Yasam, Satya Lavanya Jakki, Jawahar Natarajan, Gowthamarajan Kuppusamy. A review on novel vesicular drug delivery: proniosomes. Drug Deliv. 2013; 1-7.
4. Saroha K, Lauchab A, Kumar D, Verma S, Pratibha, Nanda S. Proniosomes: A versatile drug delivery. Int J Res Pharm Pharm Sci. 2016; 1 (2): 43-48.
5. Swati Mittal, Amit Chaudhary, Anjali Chaudhary and Ankit Kumar. Proniosomes: the effective and efficient drug-carrier system. Ther Deliv. 2020; 2019-0065.
6. Srikanth, Anand Kumar Y, Mallikarjuna Setty C. Formulation and Evaluation of Maltodextrin Based Doxorubicin HCl Proniosomes. Research J. Pharm. and Tech. 2019; 12 (6): 2776-2780.
7. Maryam khatoon, Kiyafat ullah shah, Fakhar ud din, Shefaat ullah shah, Asim ur rehman, Naz dilawar, et al. Proniosomes derived niosomes: Recent advancements in drug delivery and targeting. Drug delivery. 2017; 24 (2): 56-69.
8. Gopala Krishna Murthy TE, Sai Kishore V. Formulation and Evaluation of Transdermal Gels of Diltiazem Hydrochloride. Indian J Pharm Educ Res. 2008; 42 (3): 272-276.
9. Samita Singla, Hari Kumar SL, Geeta Aggarwal. Proniosomes for Penetration Enhancement in Transdermal System. Int J Drug Dev & Res. 2012; 4 (2): 1-13.
10. Khanderao R.Jadhav, Ashish Y.Pawar, Ashwini A.Bachhav, Satish A.Ahire. Proniosome: A Novel Non-ionic Provesicules as Potential Drug Carrier. Asian J Pharm. 2016; 10 (3): S210-S222.
11. Varsha VR, Savitha SK. Proniosomes: As a potential drug delivery system. J Pharm Sci & Res. 2019; 11 (7): 2594-2597.
12. Srikanth K, Nappinnai M and Gupta VRM. Proniosomes: A Novel Drug Carrier System. Research J. Pharm. and Tech. 2010; 3 (3): 709-711.
13. Didem Ag Seleci, Muharrem Seleci, Johanna-Gabriela Walter, Frank Stahl, Thomas Scheper. Niosomes as Nanoparticular Drug Carriers: Fundamentals and Recent Applications. J Nanomater. 2016; 1-13.
14. Kondawar MS, Kamble KG, Malusare MK, Waghmare JJ and Shah ND. Proniosome Based Drug Delivery System for Clotrimazole. Research J. Pharm. and Tech. 2011; 4 (8): 1284-1287.
15. Radha GV, Sudha Rani T, Sarvani B. A review on proniosomal drug delivery system for targeted drug action. J Basic Clin Pharm. 2013; 4 (2): 42-48.
16. Kaur Prabhjot, Kaur Loveleenpreet. Niosomes used as Targeting Drug Delivery System: A Overview. Asian J. Research Chem. 2014; 7 (7): 687-692.
17. Sulthana AA, Boby Johns George, Jeny Samuel, Noby Thomas, Daisy PA, Betty Carla. Proniosomes: A Future Revolutionary Drug Delivery System. Int J Pharm Biol Sci. 2015; 5 (4): 879-882.
18. Jangam Payal R, Thombre Nilima A, Gaikwad Pallavi N. A Review: Proniosomes as a Novel Drug Delivery System. Asian J Pharm Tech. 2017; 7 (3): 166-174.
19. Rishikesh Gupta, Santosh Kumar, Nikhil Gupta, Anurag Kumar. The new advancement nanotechnology: Proniosomes as a promising and potential drug carrier. Int J Res Dev Pharm L Sci. 2014; 3 (6): 1258-1265.
20. Dibyalochan Mohanty, Jhansi M, Dr.Vasudha Bakshi, Akiful Haque M, Swapna S, Chinmaya Keshari Sahoo, Atul Kumar Upadhyay. Niosomes: A Novel Trend in Drug Delivery. Research J. Pharm. and Tech 2018; 11 (11): 5205-5211.
21. Rishu Kakar, Rekha Rao, Anju Goswami, Sanju Nanda, Kamal Saroha. Proniosomes: An Emerging Vesicular System in Drug Delivery and Cosmetics. Der Pharmacia Lettre. 2010; 2 (4): 227-239.
22. Shweta Vashist, Jyoti Kaushik, Batra K.Sunil. A Review Article: Proniosomes. PharmaTutor. 2015; 3 (7): 25-30.
23. Nadeem farooqui, Mousumi kar, Ravindra pal singh. Formulation and development of proniosomal gel for transdermal delivery of ketorolac tromethamine. Asian J Pharm. 2016; 10 (3): S394-S400.
24. Ankur gupta, Sunil kumar prajapati, Bala murugan M, Mamta singh, Daksh Bhatia. Design and development of a proniosomal transdermal drug delivery system for captopril. Trop J Pharm Res. 2007; 6 (2): 687-693.
25. Prem Kumar Y, Vinod Kumar K, Sai Kishore V. Preparation and Evaluation of Diclofenac Niosomes by Various Techniques. Research J. Pharm. and Tech. 2013; 6 (10): 1097-1101.
26. Salve P.S. Development and evaluation of topical drug delivery system for terbinafine hydrochloride using niosomes. Res. J. Topical and Cosmetic Sci. 2011; 2 (2): 52-63.
27. Viney lather, Dharmpal Sharma, Deepti pandita. Proniosomal gel- mediated transdermal delivery of bromocriptine: in vitro and ex vivo evaluation. J Exp Nanosci. 2016; 11 (13): 1044-1057.
28. Venkata ramesh yasam, Satya lavanya jakki, Jawahar natarajan, Senthil venkatachalam, Gowthamarajan kuppusamy, Sumeet sood, et al. A novel vesicular transdermal delivery of nifedipine- preparation, characterization and in vitro/in vivo evaluation. Drug Deliv. 2016; 23 (2): 619-630.
29. Ming Ming Wen, Ragwa M.Farid, Abeer A.Kassem. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid. J Liposome Res. 2014; 24 (4): 280-289.
30. Ashish Kute, Prakash Goudanavar, Doddayya Hiremath, S.R. Reddy. Development and Characterization of Perindopril Erbumine Loaded Proniosomal Gel. Asian J. Pharm. Tech. 2012; 2 (2): 54-58.
31. Sandeep Gupta, Dheeraj Ahirwar, Neeraj K Sharma, and Deenanath Jhade. Proniosomal Gel as a Carrier for Improved Transdermal Delivery of Griseofulvin: Preparation and In-Vitro Characterization. Research J. Pharma. Dosage Forms and Tech. 2009; 1 (1): 33-37.
32. Singh S, Trivedi S, Jain S. Design and development of proniosome based transdermal delivery of ondansetron hydrochloride. Int J Appl Pharm Biol Res. 2012; 3 (5): 191-201.
33. Sharda Sambharkar, Sarvesh Paliwal, Swapnil Sharma, Bishambar Singh. Formulation of risperidone loaded proniosomes for effective transdermal delivery: An in vitro and in vivo study. Bull Fac Pharm (Cairo Univ). 2017; 55: 239-247.
34. OECD guidelines for testing of chemicals. 2015. Available from: https://www.oecd.org/env/test-no-404-acute-dermal-irritation-corrosion-9789264242678-en.htm.
35. Sudhamani T, Priyadarisini N, Radhakrishnan M. Proniosomes-A Promising Drug Carriers. Int J PharmTech Res. 2010; 2 (2): 1446-1454.
36. Desale Kishor B, Darekar A.B., Saudagar R.B. An Overview a Novel Trend in Drug Delivery: Niosomes. Res. J. Pharm. Dosage Form. & Tech. 2016; 8 (3): 211-217.
37. Waghmode Maya, Shruti Ashar. Proniosomal drug delivery systems: An overview. Int J Pharm Chem Sci. 2012; 1 (3): 1044-1056.
38. Narasimha Rao N, Srinivasa Babu P, Dihitha Chowdary A, Divya Y, Sri Laksmi T, Sai Sneha Latha K, Sirisha P. Niosomes: A Vesicular Drug Delivery System. Research J. Pharm. and Tech 2018; 11 (8): 3731-3736.
39. Gondkar S.B., Nikita S.Malekar, Dr.R.B.Saudagar. An Overview on Trends and Development of Niosomes as Drug Delivery. Research J. Topical and Cosmetic Sci. 2016; 7 (2): 79-85.